Posted by Michael Wonder on 13 Dec 2016
FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee
14 December 2016 - The U.S. FDA today approved Maci (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients.
Maci is the first FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient’s own knee.
